Tuesday, May 30, 2017

Biologics before triple therapy not cost effective for rheumatoid arthritis

Stepping up to biologic therapy when methotrexate monotherapy fails offers minimal incremental benefit over using a combination of drugs known as triple therapy, yet incurs large costs for treating rheumatoid arthritis (RA), research concludes.



from Top Health News – ScienceDaily http://ift.tt/2rARnlM
from Tumblr http://ift.tt/2qw5F7g

No comments:

Post a Comment